As such, Rab11 influences the amount of CTLA‐4 at the plasma membrane and so this specific step may be of interest in potential therapies that hope to more subtly regulate CTLA‐4 function, to treat autoimmune conditions or cancer. Here, CTLA4 is linked to cancer.